Diligence memo · auto-generated · as of July 2, 2026

Alleviant Medical, Inc.

Alleviant Medical, Inc. looks fair against its niche peers and is quiet on financing cadence.

SourceRaising on rhythm with a 2.1× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

Alleviant Medical, Inc. operates in Healthtech, based in AUSTIN.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Alleviant Medical, Inc. has raised $149M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $91M on 2024-12-19.

Most recent recorded round closed around 2024-12-19.

Valuation (modeled)modeled

Provath models Alleviant Medical, Inc. at approximately $677M (range $330M–$965M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.39× the median modeled value of Series C Healthtech companies in 2022–2024 (39 peers) — value vs value, same stage and era. Within the normal band (139% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 21 months.

Last raise 18 mo ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

The last round stepped up 2.1× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 97% of Healthtech peers (2138 compared).

Modeled value ranks above 95% of those peers.

Closest niche peers: Freedom Dental Funding, LLC, Elevate Care International Topco LP, Athelas Inc., Hazel Health, Inc., Health Gorilla, Inc..

Peoplefiled

19 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.